Literature DB >> 18940304

Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease.

Lynette L Craft1, Jack M Guralnik, Luigi Ferrucci, Kiang Liu, Lu Tian, Michael H Criqui, Jin Tan, Mary M McDermott.   

Abstract

Higher levels of inflammation are associated with adverse outcomes in patients with lower extremity peripheral arterial disease (PAD). This study evaluated associations of physical activity during daily life with levels of inflammatory biomarkers, D-dimer, and homocysteine in patients with PAD. Participants were 244 men and women (mean age 74.4 +/- 8.2 years) with PAD (ankle brachial index <0.90). C-reactive protein, interleukin-6, soluble intracellular adhesion molecule-1, soluble vascular cellular adhesion molecule-1, D-dimer, and homocysteine were assessed at study entry. Physical activity was objectively assessed with a vertical accelerometer, which participants wore continuously for 7 days. After adjusting for age, gender, race, body mass index, smoking, co-morbidities, ankle brachial index, and other potential confounders, higher physical activity levels were associated linearly and significantly with lower levels of all measured circulating biomarkers: soluble vascular cellular adhesion molecule-1 (p trend = 0.001), D-dimer (p trend = 0.005), homocysteine (p trend = 0.006), interleukin-6 (p trend = 0.010), C-reactive protein (p trend = 0.028), and soluble intracellular adhesion molecule-1 (p trend = 0.033). In conclusion, higher levels of physical activity were associated independently with lower levels of inflammatory markers, homocysteine, and D-dimer in patients with PAD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940304      PMCID: PMC3404486          DOI: 10.1016/j.amjcard.2008.06.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Physical activity during daily life and mortality in patients with peripheral arterial disease.

Authors:  Parveen K Garg; Lu Tian; Michael H Criqui; Kiang Liu; Luigi Ferrucci; Jack M Guralnik; Jin Tan; Mary M McDermott
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

2.  Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.

Authors:  N Mitsiopoulos; R N Baumgartner; S B Heymsfield; W Lyons; D Gallagher; R Ross
Journal:  J Appl Physiol (1985)       Date:  1998-07

3.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

4.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

5.  Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).

Authors:  Joshua A Beckman; Ori Preis; Paul M Ridker; Marie Gerhard-Herman
Journal:  Am J Cardiol       Date:  2005-09-27       Impact factor: 2.778

6.  Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.

Authors:  M Tschopl; D A Tsakiris; G A Marbet; K H Labs; K Jäger
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

7.  The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing.

Authors:  M H Criqui; J O Denenberg; C E Bird; A Fronek; M R Klauber; R D Langer
Journal:  Vasc Med       Date:  1996       Impact factor: 3.239

8.  Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.

Authors:  Scott E Musicant; Lloyd M Taylor; Dawn Peters; Robert A Schuff; Rakhee Urankar; Gregory J Landry; Gregory L Moneta
Journal:  J Vasc Surg       Date:  2006-04       Impact factor: 4.268

9.  Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin.

Authors:  H Sugiuchi; Y Uji; H Okabe; T Irie; K Uekama; N Kayahara; K Miyauchi
Journal:  Clin Chem       Date:  1995-05       Impact factor: 8.327

10.  Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study.

Authors:  W R Hiatt; S Hoag; R F Hamman
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

View more
  9 in total

Review 1.  Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.

Authors:  Joe F Lau; Mitchell D Weinberg; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

Review 2.  Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits.

Authors:  Naomi M Hamburg; Gary J Balady
Journal:  Circulation       Date:  2011-01-04       Impact factor: 29.690

3.  Association of monocyte tumor necrosis factor α expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease.

Authors:  Reena L Pande; Jonathan Brown; Stewart Buck; Whitney Redline; Jeanne Doyle; Jorge Plutzky; Mark A Creager
Journal:  J Vasc Surg       Date:  2014-08-02       Impact factor: 4.268

4.  A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results.

Authors:  Justin C Brown; Andrea B Troxel; Bonnie Ky; Nevena Damjanov; Babette S Zemel; Michael R Rickels; Andrew D Rhim; Anil K Rustgi; Kerry S Courneya; Kathryn H Schmitz
Journal:  Contemp Clin Trials       Date:  2016-03-10       Impact factor: 2.226

5.  Applying the ecological model of behavior change to a physical activity trial in retirement communities: description of the study protocol.

Authors:  Jacqueline Kerr; Dori E Rosenberg; Andrea Nathan; Rachel A Millstein; Jordan A Carlson; Katie Crist; Kari Wasilenko; Khalisa Bolling; Cynthia M Castro; David M Buchner; Simon J Marshall
Journal:  Contemp Clin Trials       Date:  2012-08-17       Impact factor: 2.226

6.  Effect of in-hospital physical activity on cardiovascular prognosis in lower extremity bypass for claudication.

Authors:  Tomohiro Matsuo; Taichi Sakaguchi; Atsuhisa Ishida; Satoshi Yuguchi; Kazuya Saito; Masaharu Nakajima; Takuya Ujikawa; Tomoyuki Morisawa; Genta Chikazawa; Tetsuya Takahashi
Journal:  J Phys Ther Sci       Date:  2015-06-30

7.  High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacity Are Not Affected by Supervised Exercise but Are Associated with Baseline Interleukin-6 in Patients with Peripheral Artery Disease.

Authors:  Mazen S Albaghdadi; Zheng Wang; Ying Gao; R Kannan Mutharasan; John Wilkins
Journal:  Front Cardiovasc Med       Date:  2017-03-02

8.  Nonexercise physical activity and inflammatory and oxidative stress markers in women.

Authors:  Sheng Hui Wu; Xiao Ou Shu; Wong-Ho Chow; Yong-Bing Xiang; Xianglan Zhang; Hong-Lan Li; Qiuyin Cai; Ginger Milne; Bu-Tian Ji; Hui Cai; Nathaniel Rothman; Yu-Tang Gao; Wei Zheng; Gong Yang
Journal:  J Womens Health (Larchmt)       Date:  2013-10-29       Impact factor: 2.681

9.  Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions.

Authors:  Sibel Ertek; Arrigo Cicero
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.